491 followers
RT @FrontOncology: New research: Heterozygous p53-R280T Mutation Enhances the Oncogenicity of NPC Cells Through Activating PI3K-Akt Signali…
RT @FrontOncology: New research: Heterozygous p53-R280T Mutation Enhances the Oncogenicity of NPC Cells Through Activating PI3K-Akt Signali…
RT @FrontOncology: New research: Heterozygous p53-R280T Mutation Enhances the Oncogenicity of NPC Cells Through Activating PI3K-Akt Signali…
New research: Heterozygous p53-R280T Mutation Enhances the Oncogenicity of NPC Cells Through Activating PI3K-Akt Signaling Pathway: A heterozygous point mutation of p53 gene at codon 280 from AGA to ACA (R280T) frequently occurs in… https://t.co/XA48tkrVyA